Samsung Biologics, a leading contract development and manufacturing organization, announced Wednesday that the company’s earnings in the first quarter this year hit an all-time high. In the January-March period, Samsung Biologics’ sales increased by 31.3 percent on-year to 946.9 billion won ($690 million) from the previous year’s 720.9 billion won. Its operating profit also reached 221.3 billion won.
SABA announces historic agreements to purchase SAF certificates | Biofuels International Magazine
biofuels-news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biofuels-news.com Daily Mail and Mail on Sunday newspapers.
04 24 24 -- Maximizing Biologics Potential Through Integrated Services For Faster Timelines
lifescienceleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lifescienceleader.com Daily Mail and Mail on Sunday newspapers.
Demand for Active Pharmaceutical Ingredients Fuels Market Growth, Expected to Surpass USD 372 8 Billion by 2031
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.
04 23 24 -- Maximizing Biologics Potential Through Integrated Services For Faster Timelines
pharmaceuticalonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceuticalonline.com Daily Mail and Mail on Sunday newspapers.